Biomedicine is an industry that is most likely to bring China’s innovative technologies and products to the world and serve all mankind. It is an industry with strategic significance. At the moment，biomedicine has become a hot spot for scientists to start businesses and investors to go for，and it has become a key area for local economic development. The development of biomedicine in China has the advantages of large population，large market scale，low cost of clinical trials，and relatively easy selection of subjects. However，there are also disadvantages such as weak basic research，low income level of residents，and limited market affordability. Doing innovative drugs in China is not easy，and it is even more difficult to develop innovative drugs. Biomedical research and development is a cash-burning industry that entails large capital. The high risk of innovative drugs should correspond to high returns. The pricing of innovative drugs is a process of exploring to have a rational price. We should fully understand the business model of China’s innovative drugs and the importance of stabilizing market expectations. We should support innovation from a strategic perspective，encourage innovation，promote high-quality and efficient supervision，build a multi-level medical security system，and strengthen the cooperations among scientists，industries，cooperation and regulators.